EP753 Single centre experience with anti-PD1 therapy in gynaecologic cancers
EP753 Single centre experience with anti-PD1 therapy in gynaecologic cancers
About this item
Full title
Author / Creator
Publisher
Kidlington: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Introduction/BackgroundThe prognosis of women with gynaecologic malignancies which progress after standard oncological treatment remains poor. While immune checkpoint inhibitors targeting the PD1/PDL1 pathway have provided durable responses in various tumour types, their use in gynaecologic oncology is an area of active research.MethodologyWe retro...
Alternative Titles
Full title
EP753 Single centre experience with anti-PD1 therapy in gynaecologic cancers
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2552904910
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552904910
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2019-ESGO.805
